Novartis (Signifor,Signifor LAR and Osilodrostat) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Novartis (Signifor,Signifor LAR and Osilodrostat) General Information

Description

Medical rights for the treatment of Cushing disease. The rights are used for the treatment of Cushing's disease and acromegaly in adult patients for whom surgery is not an option or for whom surgery has failed.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Basel
  • Switzerland
Primary Industry
Buildings and Property
Other Industries
Other Healthcare Services
Acquirer
Corporate Office
  • Basel
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novartis (Signifor,Signifor LAR and Osilodrostat) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novartis (Signifor,Signifor LAR and Osilodrostat)‘s full profile, request access.

Request a free trial

Novartis (Signifor,Signifor LAR and Osilodrostat) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Novartis (Signifor,Signifor LAR and Osilodrostat)‘s full profile, request access.

Request a free trial

Novartis (Signifor,Signifor LAR and Osilodrostat) FAQs

  • Where is Novartis (Signifor,Signifor LAR and Osilodrostat) headquartered?

    Novartis (Signifor,Signifor LAR and Osilodrostat) is headquartered in Basel, Switzerland.

  • What industry is Novartis (Signifor,Signifor LAR and Osilodrostat) in?

    Novartis (Signifor,Signifor LAR and Osilodrostat)’s primary industry is Buildings and Property.

  • Is Novartis (Signifor,Signifor LAR and Osilodrostat) a private or public company?

    Novartis (Signifor,Signifor LAR and Osilodrostat) is a Private company.

  • What is the current valuation of Novartis (Signifor,Signifor LAR and Osilodrostat)?

    The current valuation of Novartis (Signifor,Signifor LAR and Osilodrostat) is .

  • What is Novartis (Signifor,Signifor LAR and Osilodrostat)’s current revenue?

    The current revenue for Novartis (Signifor,Signifor LAR and Osilodrostat) is .

  • Who are Novartis (Signifor,Signifor LAR and Osilodrostat)’s investors?

    Novartis has invested in Novartis (Signifor,Signifor LAR and Osilodrostat).

  • When was Novartis (Signifor,Signifor LAR and Osilodrostat) acquired?

    Novartis (Signifor,Signifor LAR and Osilodrostat) was acquired on 23-Oct-2019.

  • Who acquired Novartis (Signifor,Signifor LAR and Osilodrostat)?

    Novartis (Signifor,Signifor LAR and Osilodrostat) was acquired by Recordati.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process